Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 Stock Report

Market Cap: CN¥2.9b

Jiangsu Hualan New Pharmaceutical MaterialLtd Balance Sheet Health

Financial Health criteria checks 6/6

Jiangsu Hualan New Pharmaceutical MaterialLtd has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.5B and CN¥241.6M respectively. Jiangsu Hualan New Pharmaceutical MaterialLtd's EBIT is CN¥34.6M making its interest coverage ratio -0.9. It has cash and short-term investments of CN¥683.6M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-0.9x
CashCN¥683.65m
EquityCN¥2.23b
Total liabilitiesCN¥241.57m
Total assetsCN¥2.47b

Recent financial health updates

No updates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Financial Position Analysis

Short Term Liabilities: 301093's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥160.1M).

Long Term Liabilities: 301093's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥81.5M).


Debt to Equity History and Analysis

Debt Level: 301093 is debt free.

Reducing Debt: 301093 has no debt compared to 5 years ago when its debt to equity ratio was 41.6%.

Debt Coverage: 301093 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301093 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies